UW Madison Psychedelic Symposium Enduring
The University of Wisconsin Madison Transdisciplinary Center for Research in Psychoactive Substances is pleased to announce our 2021 Psychedelic Symposium, offered on November 4th & 5th, 2021, is now available as an enduring online activity.
The Symposium was held on campus in the Wisconsin Institutes of Discovery DeLuca Forum. Highlighting scholarly work being performed in this field at the UW-Madison, as well as featuring nationally renowned keynote speakers, this activity is intended for researchers and clinicians in the areas of clinical psychology, psychiatry, pharmacy, nursing, and social work and offers continuing education hours.
The activity includes updates on the exploratory use of MDMA in the treatment of PTSD, and psilocybin for depression and substance use disorders. The phenomenology of psychedelic experiences is discussed, as well as historical, environmental, and cultural implications of the use of traditional psychedelics. Barriers to access to this clinical research that exist for underserved populations are explored, along with suggestions to address these barriers and expand access in future research.
Intended Audience
Pharmacist
Physician
Nurse
Psychologist
Learning Objectives
As a result of participating in this symposium, learners should be able to:
- Describe the neuropharmacology of psilocybin and MDMA, noting their similaries and differences.
- Describe the common and rarer but serious adverse effects of psilocybin and MDMA, and other related drugs.
- Describe the processes of patient selection, preparation, and treatment, and how these are intended to minimize adverse effects and maximize therapeutic benefits.
- Describe the cultural, historic, and socioeconomic barriers to therapeutic treatments with psychedelics.
- Describe the steps for developing a drug for FDA approval, and how the process for psilocybin and MDMA is likely to be different from related psychoactive drugs.
- Describe the different chemical classes of psychedelics, including similarities and differences in effect and time course of effect.
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are provided at the Symposium.
INSTRUCTORS
Matthew Banks, PhD, Professor, School of Medicine and Public Health, Madison, WI
Randy Brown, MD, PhD, DFASAM, Associate Professor with Tenure, Department of Family Medicine and Community Health; Director, University of Wisconsin Addiction Medicine Fellowship Training Program, University of Wisconsin School of Medicine and Public Health; Staff Addictionologist, HIV Comprehensive Care Center University of Wisconsin Hospital and Clinics, Madison, Wisconsin
John Dunne, PhD, Distinguished Professor of Contemplative Humanities, Chair Department of Asian Languages & Cultures and Core Faculty, Center for Healthy Minds, University of Wisconsin-Madison, Madison, WI
Peter S. Hendricks, PhD, (Clinical Psychologist), Professor & Director of Research, Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL
Paul Hutson, PharmD, BCOP, Professor, Pharmacy Practice Division, UW-Madison School of Pharmacy, Madison, WI
Charles L. Raison, MD, Mary Sue and Mike Shannon Distinguished Chair for Healthy Minds, Children & Families, Professor, School of Human Ecology, and Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI
Lucas Richert, PhD, Associate Professor, George Urdang Chair in the History of Pharmacy Director of Graduate Studies, Health Services Research in Pharmacy Graduate Program, UW Madison School of Pharmacy, Madison, WI
Chantelle Thomas, PhD, Research Associate, Department of Family Medicine and Community Health, School of Medicine and Public Health, Madison, Wisconsin, and Executive Clinical Director, Windrose Recovery, Brookfield, Wisconsin
Alberto Vargas, PhD, Associate Director Latin American, Caribbean and Iberian Studies Program, University of Wisconsin-Madison
Cody Wenthur, PharmD, PhD, Assistant Professor and Director, MS in Psychoactive, Pharmaceutical Investigation, University of Wisconsin-Madison School of Pharmacy, Madison, WI
PLANNING COMMITTEE
Paul Hutson, PharmD, BCOP, Professor, Pharmacy Practice Division, UW-Madison School of Pharmacy, Madison, WI
Megan Miller, PhD, RN, Postdoctoral Research Associate, UW-Madison School of Nursing, Madison, WI
Christopher Nicholas, PhD, Assistant Professor (CHS), Clinical Psychologist, School of Medicine and Public Health, Madison, Wi
Charles Raison, MD, Professor, UW-Madison School of Human Ecology, Madison, WI
Lucas Richert, PhD, Associate Professor, Social and Administrative Sciences Division, George Urdang Chair in the History of Pharmacy, Driector of Graduate Studies, Health Services Research in Pharmacy Graduate Program, UW-Madison School of Pharmacy, Madison, WI
Cody Wenthur, PharmD, PhD, Assistant Professor, Pharmacy Practice Division, UW-Madison School of Pharmacy, Madison, WI
Angela Willits, MSW, LCSW, Clinical Assistant Professor, MSW Program Director, UW-Madison School of Social Work, Madison, WI
Accreditation Statement
In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
The University of Wisconsin–Madison ICEP designates this enduring knowledge based activity for 7.0 hours or 0.7 CEUs of CPE credit. Credit can be earned by successfully completing the activity, the assessment and the evaluation. There will be no partial credit awarded for partial completion.
ACPE# JA0000358-0000-22-152-H04-P
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of 7.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of 7.0 ANCC contact hours.
American Psychological Association (APA)
![]() | Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs. |
Continuing Education Units (CEUs)
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.70 CEUs or 7.0 hours.
Available Credit
- 7.00 AMA PRA Category 1 Credit™
- 7.00 ANCC Contact Hours
- 7.00 APA CE Credits
- 7.00 University of Wisconsin–Madison Continuing Education Hours
- 7.00 Approved for AMA PRA Category 1 Credit™